These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Comparison of the incidence of late stent thrombosis after implantation of different drug-eluting stents in the real world coronary heart disease patients: three-year follow-up results. Chen JL, Gao LJ, Yang YJ, Li JJ, Qiao SB, Xu B, Huang JH, Yao M, Qin XW, Liu HB, Wu YJ, Yuan JQ, Chen J, You SJ, Dai J, Gao RL. Chin Med J (Engl); 2010 Apr 05; 123(7):778-81. PubMed ID: 20497663 [Abstract] [Full Text] [Related]
7. Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET. Pfisterer M, Brunner-La Rocca HP, Rickenbacher P, Hunziker P, Mueller C, Nietlispach F, Leibundgut G, Bader F, Kaiser C, BASKET. Eur Heart J; 2009 Jan 05; 30(1):16-24. PubMed ID: 19033260 [Abstract] [Full Text] [Related]
9. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Park DW, Park SW, Park KH, Lee BK, Kim YH, Lee CW, Hong MK, Kim JJ, Park SJ. Am J Cardiol; 2006 Aug 01; 98(3):352-6. PubMed ID: 16860022 [Abstract] [Full Text] [Related]
15. Late and very late thrombosis of drug-eluting stents: evolving concepts and perspectives. Jaffe R, Strauss BH. J Am Coll Cardiol; 2007 Jul 10; 50(2):119-27. PubMed ID: 17616295 [Abstract] [Full Text] [Related]
18. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison. Brugaletta S, Burzotta F, Trani C, Todaro D, Talarico G, Porto I, Leone AM, Niccoli G, Mazzari MA, Mongiardo R, Schiavoni G, Crea F. Minerva Cardioangiol; 2008 Feb 10; 56(1):35-42. PubMed ID: 18432167 [Abstract] [Full Text] [Related]
19. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale. Ribichini F, Tomai F, De Luca G, Boccuzzi G, Presbitero P, Pesarini G, Ferrero V, Ghini AS, Pastori F, De Luca L, Zavalloni D, Soregaroli D, Garbo R, Franchi E, Marino P, Minelli M, Vassanelli C. J Cardiovasc Med (Hagerstown); 2009 Feb 10; 10(2):192-9. PubMed ID: 19377384 [Abstract] [Full Text] [Related]
20. Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry. Ortolani P, Balducelli M, Marzaroli P, Piovaccari G, Menozzi A, Guiducci V, Sangiorgio P, Tarantino F, Geraci G, Castriota F, Tondi S, Saia F, Cooke RM, Guastaroba P, Grilli R, Marzocchi A, Maresta A. Circulation; 2008 Feb 19; 117(7):923-30. PubMed ID: 18250265 [Abstract] [Full Text] [Related] Page: [Next] [New Search]